Related Experiment Video

Updated: Feb 20, 2026

Intracranial Cannula Implantation for Serial Locoregional Chimeric Antigen Receptor CAR T Cell Infusions in Mice
05:22

Intracranial Cannula Implantation for Serial Locoregional Chimeric Antigen Receptor CAR T Cell Infusions in Mice

Published on: February 24, 2023

4.3K

CAR-T cell immunotherapy in rhabdomyosarcoma

Pooria Safarzadeh Kozani1,2, Setareh Dashti Shokoohi3, Pouya Safarzadeh Kozani4,5

  • 1Research and Development Center of Biotechnology, Tarbiat Modares University, Tehran, Iran. pooriasafarzadeh@modares.ac.ir.

Journal of Translational Medicine
|February 19, 2026
PubMed
Summary

No abstract available in PubMed .

Keywords:
Adoptive cell therapyCancer immunotherapyChimeric antigen receptorRhabdomyosarcomaSoft tissue sarcoma

More Related Videos

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care12:55

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Published on: February 16, 2015

22.1K
Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography09:34

Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography

Published on: February 17, 2022

3.9K

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.0K